|
| |
|
 |
|
|
| [DISPLAY PATENT] |
| |
| |
|
|
| Application no. and date | 03778516.9 (espacenet) (Federated) (European Patent Register), 20031126 | | Patent/reg. no. and date | DK/EP 1567667, 20081015 | | Publication date | 20050831 | | Priority no. and date | GB 0228079, 20021202 | | EP pub. no. and date |
EP 1567667 20050831 | | Effective date | | | Applicant/owner | Amarin Neuroscience Limited, Kings Park House
Laurelhill Business Park
Polmaise Road
Stirling FK7 9JQ, GB | | Applicant ref. no. | P80829810DK00E | | Inventor | HORROBIN, David Frederick,
deceased, GB | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 31/00 (2006.01) , A61P 25/28 (2006.01) , C12Q 1/68 (2006.01) | | Title | Behandling af Huntington´s sygdom med EPA | | Int. application no. | GB2003005131 | | Int. publication no. | WO2004050913 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
|
|
|
|
